Single-Row Versus Double-Row Repair for Achilles Insertional Tendinopathy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorWomen's College Hospital
About this trial
Achilles insertional tendinopathy may require surgical debridement and tendon reattachment when non-operative treatment fails. Single-row and double-row repairs are used, with biomechanical studies favoring double-row, but clinical evidence of improved outcomes is lacking and costs are higher. This multi-center randomized trial will use the VISA-A score to compare outcomes and inform cost-effective, evidence-based surgical care.
Eligibility criteria
Qualifiers
Must be deemed to have capacity to provide informed consent;
Must sign and date the informed consent form;
Stated willingness to comply with all study procedures;
Adult patients between the ages of 18 and 75 years with symptomatic chronic Achilles insertional tendinopathy for a minimum of 3 months
Disqualifiers
Non-insertional Achilles tendinopathy;
Achilles tendon rupture;
Previous Achilles tendon surgery;
Oral steroid use or steroid injection within 3 months of surgery;
Trial design
Treatments tested in this trial
- Single-row repair of the Achilles tendon at its calcaneal insertion
- Double-row repair of the Achilles tendon at its calcaneal insertion
Treatment groups
166 Participants
are divided into 2 treatment groupsLocations
1Women's College HospitalM5S 1B2, TorontoOntario, Canada
Sponsors and collaborators
Women's College Hospital
Lead sponsor
The Physicians' Services Incorporated Foundation
Collaborator
University Health Network, Toronto
Collaborator
Unity Health Toronto
Collaborator
University of Toronto
Collaborator
Source ClinicalTrials.gov